Brazil Cardiovascular Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
Market Report I 2025-06-01 I 68 Pages I Mordor Intelligence
Brazil Cardiovascular Devices Market Analysis
The Brazil Cardiovascular Devices Market size is estimated at USD 304.36 million in 2025, and is expected to reach USD 370.94 million by 2030, at a CAGR of 4.04% during the forecast period (2025-2030).
Demand is fueled by rising coronary disease prevalence in large cities, rapid uptake of transcatheter therapies in the Southeast, and continued expansion of supplementary health plans that make advanced treatments more affordable. Multinational leaders are investing aggressively even as long ANVISA timelines delay local launches and skilled-staff shortages hamper high-complexity device adoption . Digital health rules now require broader use of remote cardiac monitoring, positioning connected diagnostics to capture incremental procedure volumes across public and private systems.
Brazil Cardiovascular Devices Market Trends and Insights
Rising Prevalence of Coronary Artery Disease in Brazil's Urban Centers
Cardiovascular morbidity is climbing sharply in Sao Paulo, Rio de Janeiro and other metropolises as the share of residents aged ?65 heads to 13.6% by 2030. Uneven primary-care performance-worst in the Southeast-pushes more patients toward interventional solutions rather than prevention . Diagnostic cardiac imaging guidelines released in 2024 emphasize CT and MRI as first-line tools, spurring equipment upgrades across referral hospitals [2]. Private health insurers cover over half of specialty consultations, supporting broader access to stents, valves and rhythm devices. Collectively, these factors elevate procedure volumes and reinforce the cardiovascular devices market growth outlook.
Privatization-Fueled Growth of Supplementary Health Insurance Plans Boosting Device Affordability
Brazil's private payer base keeps expanding, helped by hospital consolidation such as the proposed Dasa-Amil merger that would create a 4,500-bed network with USD 2 billion in annual sales. Larger systems negotiate bulk discounts yet also demand newer technology, raising throughput for transcatheter valves and intracardiac monitors. Reimbursement studies show intensive-care tariffs increase in line with provider market share, allowing investors to recoup capital expenditures on high-end devices sooner. Supplementary plans now cover a broader list of cardiovascular interventions approved by ANS in October 2024, widening eligibility for minimally invasive procedures [1]. Greater disposable income among insured urban dwellers accelerates elective uptake, supporting the cardiovascular devices market trajectory through 2030.
Skilled Electrophysiologist Shortage Constricting Advanced CRM Implant Volumes
Only a limited pool of clinicians is certified to implant high-complexity rhythm systems, especially outside tier-one metros. Training audits in 2024 found ICU nurses underprepared to manage real-time device data, reflecting broader skills gaps bmcnursing. Professional societies are rolling out virtual mentoring and sustainability programs yet scaling remains slow. Regional inequality is stark: the Southeast already struggles with basic primary care metrics, implying even tighter capacity for sophisticated electrophysiology. The shortage restricts implant throughput for leadless CRT-pacers that entered clinical routine after promising 2024 trial results. As staffing pipelines mature slowly, the constraint weighs on the cardiovascular devices market expansion into the next decade.
Other drivers and restraints analyzed in the detailed report include:
Rapid Adoption of Transcatheter Therapies in Southeast Brazil / Digital Health Integration Mandates Accelerating Remote Cardiac Monitoring Uptake / Restraint Impact Analysis / /
For complete list of drivers and restraints, kindly check the Table Of Contents.
Segment Analysis
In 2024 diagnostic and monitoring products captured 58.20% of the cardiovascular devices market size and are advancing at a 6.13% CAGR to 2030, reflecting guideline-driven adoption of cardiac CT and MRI in major centers. Uptake also rides on the rollout of cloud-based ECG platforms that feed AI algorithms for arrhythmia detection. Therapeutic segments grow more slowly yet remain strategic. Cardiac rhythm management benefits from Boston Scientific's modular leadless system that posted high implant success at ESC 2024, prompting Brazilian electrophysiologists to prepare for broader deployment once ANVISA approves. Transcatheter heart valves represent the fastest unit growth as Medtronic and Abbott channel inventory into urban hubs soon after CE-level clearances medtronic. Investments totaling USD 25.01 billion in rhythm devices worldwide indicate a pipeline of miniaturized implants and ablation tools that will expand the cardiovascular devices industry footprint in Brazil over the medium term.
The Report Covers Brazil Cardiovascular Devices Market Trends and It is Segmented by Device Type (Diagnostic and Monitoring Devices and Therapeutic and Surgical Devices), by Application (Coronary Artery Disease, Arrhythmia and More), by End User (Hospitals & Cardiac Centers, Ambulatory Surgical Centers and More) and Geography. The Report Offers the Value (in USD Million) for all the Above Segments.
List of Companies Covered in this Report:
Medtronic / Abbott Laboratories / Boston Scientific / Edwards Lifesciences Corp. / Johnson & Johnson (Biosense Webster/Cordis) / MicroPort Scientific Corp. / Terumo Corp. / LivaNova / BIOTRONIK / GE HealthCare Technologies Inc. / Koninklijke Philips / Siemens Healthineers / W. L. Gore & Associates / Getinge AB (Maquet) / AngioDynamics / Penumbra / Shockwave Medical Inc. / LivaNova / Cardioline S.p.A. /
Additional Benefits:
The market estimate (ME) sheet in Excel format /
3 months of analyst support /
1 Introduction
1.1 Study Assumptions & Market Definition
1.2 Scope of the Study
2 Research Methodology
3 Executive Summary
4 Market Landscape
4.1 Market Drivers
4.1.1 Rising Prevalence of Coronary Artery Disease in Brazil's Urban Centers
4.1.2 Privatization-Fueled Growth of Supplementary Health Insurance Plans Boosting Device Affordability
4.1.3 Rapid Adoption of Transcatheter Therapies in Southeast Brazil
4.1.4 Digital Health Integration Mandates Accelerating Remote Cardiac Monitoring Uptake
4.1.5 Expansion of SUS-Funded High-Complexity Cardiac Procedure Reimbursement Codes
4.1.6 Localization Incentives under PDPs Driving Multinational Manufacturing Investments
4.2 Market Restraints
4.2.1 Lengthy ANVISA Approval Timelines for Novel Cardiovascular Technologies
4.2.2 Skilled Electrophysiologist Shortage Constricting Advanced CRM Implant Volumes
4.2.3 Currency Volatility Elevating Import Costs of High-End Devices
4.2.4 Limited Cath Lab Density in Northern & Northeastern Regions
4.3 Supply-Chain Analysis
4.4 Regulatory Landscape
4.5 Technology Outlook
4.6 Porter's Five Forces
4.6.1 Bargaining Power of Suppliers
4.6.2 Bargaining Power of Buyers
4.6.3 Threat of New Entrants
4.6.4 Threat of Substitutes
4.6.5 Competitive Rivalry
5 Market Size & Growth Forecasts (Value)
5.1 By Device Type
5.1.1 Diagnostic & Monitoring Devices
5.1.1.1 ECG Systems
5.1.1.2 Remote Cardiac Monitor
5.1.1.3 Cardiac MRI
5.1.1.4 Cardiac CT
5.1.1.5 Echocardiography / Ultrasound
5.1.1.6 Fractional Flow Reserve (FFR) Systems
5.1.2 Therapeutic & Surgical Devices
5.1.2.1 Coronary Stents
5.1.2.1.1 Drug-Eluting Stents
5.1.2.1.2 Bare-Metal Stents
5.1.2.1.3 Bioresorbable Stents
5.1.2.2 Catheters
5.1.2.2.1 PTCA Balloon Catheters
5.1.2.2.2 IVUS/OCT Catheters
5.1.2.3 Cardiac Rhythm Management
5.1.2.3.1 Pacemakers
5.1.2.3.2 Implantable Cardioverter Defibrillators
5.1.2.3.3 Cardiac Resynchronization Therapy Devices
5.1.2.4 Heart Valves
5.1.2.4.1 TAVR/TAVI
5.1.2.4.2 Mechanical Valves
5.1.2.4.3 Tissue/Bioprosthetic Valves
5.1.2.5 Ventricular Assist Devices
5.1.2.6 Artificial Hearts
5.1.2.7 Grafts & Patches
5.1.2.8 Other Cardiovascular Surgical Devices
5.2 By Application
5.2.1 Coronary Artery Disease
5.2.2 Arrhythmia
5.2.3 Heart Failure
5.2.4 Structural Heart Disease
5.2.5 Hypertension
5.2.6 Others
5.3 By End-User
5.3.1 Hospitals & Cardiac Centers
5.3.2 Home-Care Settings
5.3.3 Ambulatory Surgical Centers
6 Competitive Landscape
6.1 Strategic Moves
6.2 Market Share Analysis
6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
6.3.1 Medtronic plc
6.3.2 Abbott Laboratories
6.3.3 Boston Scientific Corp.
6.3.4 Edwards Lifesciences Corp.
6.3.5 Johnson & Johnson (Biosense Webster/Cordis)
6.3.6 MicroPort Scientific Corp.
6.3.7 Terumo Corp.
6.3.8 LivaNova PLC
6.3.9 BIOTRONIK SE & Co. KG
6.3.10 GE HealthCare Technologies Inc.
6.3.11 Koninklijke Philips N.V.
6.3.12 Siemens Healthineers AG
6.3.13 W. L. Gore & Associates
6.3.14 Getinge AB (Maquet)
6.3.15 AngioDynamics Inc.
6.3.16 Penumbra Inc.
6.3.17 Shockwave Medical Inc.
6.3.18 Livanova PLC
6.3.19 Cardioline S.p.A.
7 Market Opportunities & Future Outlook
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.